Similarly, results from the TGCA database (http://xena.ucsc.edu/) showed that the PCa patients with a high expression of the KIAA1524 gene with a low ratio of progression-free survival (PFS) (p = 0.0413) (Fig. 1D). This evidence concerns the gene CIP2A and posterior cortical atrophy.